 | This article has multiple issues. Please help
improve it or discuss these issues on the
talk page. (
Learn how and when to remove these template messages)
|
Agatha Jassem | |
|---|---|
| Nationality | Canadian |
| Alma mater | University of British Columbia |
| Occupation | clinical microbiologist |
Agatha Jassem is a Canadian clinical microbiologist and the program head of the Virology Lab at the British Columbia Centre for Disease Control Public Health Laboratory, [1] and a clinical assistant professor in the Department of Pathology & Laboratory Medicine at the University of British Columbia in Vancouver, British Columbia, Canada. [2]
Jassem obtained her PhD at the University of British Columbia, followed by a fellowship in Clinical Microbiology at the National Institutes of Health. [3] Her research focuses the detection of healthcare-and community-associated infections, emerging pathogens, and drug resistance determinants.
During the COVID-19 pandemic response, Jassem led research efforts on COVID-19 breakthrough infections from vaccinated individuals, [4] [5] SARS-CoV-2 population level seroprevalence, [6] antibody response [7] as well as collaborating on research on securing reagents for COVID-19 during world-wide shortages, [8] and the role of ACEII. [9]
References
- ^ "Agatha Jassem". bccdc.ca. Retrieved 2021-09-20.
- ^ "Agatha Jassem". Pathology. Retrieved 2021-09-20.[ permanent dead link]
- ^ "Agatha Jassem". Pathology. Retrieved 2021-09-20.[ permanent dead link]
- ^ "COVID-19 Smiles – The Study of Vaccine Escape Mutants | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "COVID-19 research initiatives at UBC among those funded by first-time partnership". UBC Faculty of Medicine. 2021-05-21. Retrieved 2021-09-28.
- ^ "Population-Based Study Of Coronavirus Antibody Cross-Reactivity To Inform SARS-CoV-2 Seroprevalence | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "Characterizing Antibody Response to Emerging COVID-19 Virus (CARE COVID-19) | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "Securing Reagent Supplies and Scaling COVID-19 | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
- ^ "Prognostication of ACE II Receptor (PACEiiR) | COVID-19 Research". covid19.research.ubc.ca. Retrieved 2021-09-20.
| Authority control databases: Academics |
|---|
.svg){kind=small}
 | This article about a Canadian scientist is a stub. You can help Wikipedia by expanding it. |
- Canadian microbiologists
- Academic staff of the University of British Columbia
- COVID-19 drug development
- Living people
- Canadian women biologists
- Women microbiologists
- University of British Columbia alumni
- Canadian medical researchers
- Women medical researchers
- 21st-century Canadian biologists
- 21st-century Canadian women scientists
- Canadian scientist stubs